# Zylox-Tonbridge and GL Capital invest HK$1.48B in LifeTech Scientific

Zylox-Tonbridge and GL Capital, through joint vehicle GL Lighthouse Two Investment, will invest about HK$1.482 billion ($189 million) for newly issued shares equal to about 16.7% of LifeTech Scientific's enlarged capital. Zylox-Tonbridge holds 60% of the joint vehicle and also intends to pursue a potential merger with LifeTech.

- Type: Investment
- Announced: 2026-11-10
- Where: China
- Value: $189.0M (1.48B HKD)
- Status: announced
- Products: peripheral vascular devices, neurovascular devices, aortic devices, structural heart devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LifeTech Scientific](https://endata.com/companies/38475.md) (investor)
- [Zylox-Tonbridge](https://endata.com/companies/76125.md) (investor)
- [GL Capital](https://endata.com/companies/94975.md) (investor)

## Sources

- [gsmedtech.com](https://www.gsmedtech.com/insights/article/zylox-tonbridge-and-gl-capital-invest-hk148b-in-lifetech-scientific), 2026-11-10: "Zylox-Tonbridge and GL Capital have announced a strategic investment in LifeTech Scientific, aimed at building an integrated vascular and structural heart intervention platform in China."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.